Group One Trading
CMPX icon

Group One Trading’s Compass Therapeutics CMPX Stock Holding History

Group One Trading’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.2K Buy
11,000
+9,700
+746% +$56K ﹤0.01% 5148
2025
Q4 		$6.98K Sell
1,300
-2,000
-61% -$9.23K ﹤0.01% 7017
2025
Q3 		$11.6K Buy
3,300
+900
+38% +$2.84K ﹤0.01% 7086
2025
Q2 		$6.24K Sell
2,400
-26,900
-92% -$55.5K ﹤0.01% 6987
2025
Q1 		$55.7K Buy
+29,300
New +$77.9K ﹤0.01% 5080

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Group One Trading's CMPX Position: Q1 2026 in Review

Group One Trading increased its Compass Therapeutics (CMPX) stake by 476% in Q1 2026, buying an estimated $144K and bringing the position to 30,229 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #4307.

Group One Trading first reported a position in CMPX in Q4 2025 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • Group One Trading held 30,229 shares of Compass Therapeutics worth $160K as of Q1 2026.
  • Group One Trading bought 24,985 Compass Therapeutics shares in Q1 2026, an estimated $144K.
  • Compass Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4307 holding.
  • Group One Trading first reported a position in Compass Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.